European Alliance of Associations for Rheumatology

The European Alliance of Associations for Rheumatology, commonly known as EULAR, is a European non-governmental organization focused on rheumatology and the wider field of rheumatic and musculoskeletal diseases. It brings together organizations representing people living with arthritis and related conditions, healthcare professionals, and scientific societies from European countries. This multi-constituency structure gives EULAR a role that extends beyond a conventional medical society: it connects patient advocacy, clinical expertise, scientific research, professional education, and public-policy engagement. EULAR's central purpose is to reduce the personal and societal burden of rheumatic and musculoskeletal diseases. Its work addresses the prevention, diagnosis, treatment, rehabilitation, and long-term management of conditions that can cause pain, disability, reduced mobility, and loss of participation in work and daily life. The organization seeks to improve outcomes by helping translate advances in biomedical and clinical research into routine care, while also drawing attention to the experiences and priorities of people affected by these diseases. A major part of EULAR's professional role is the development and dissemination of recommendations for the diagnosis and treatment of rheumatic and musculoskeletal diseases. These recommendations are produced through expert and stakeholder processes and are published through the organization's scientific communications channels, including the Annals of the Rheumatic Diseases. By consolidating evidence and expert assessment, EULAR contributes to the standardization and improvement of clinical practice across Europe and internationally. EULAR also supports the circulation of scientific knowledge through its publications. Its principal journal is the Annals of the Rheumatic Diseases, a specialist medical journal published by Elsevier. The organization additionally publishes EULAR Rheumatology Open, an open-access journal intended to broaden access to rheumatology research and clinical information. These publications provide venues for original research, reviews, recommendations, and other scholarly work relevant to rheumatology. The organization organizes the Annual European Congress of Rheumatology, its major scientific and professional meeting. The congress provides a forum for presenting research, discussing clinical developments, sharing educational content, and connecting patient organizations, healthcare professionals, and researchers. Alongside the congress and journals, EULAR's activities include education, advocacy, professional networking, and communication with European governing bodies about the needs of people with musculoskeletal diseases. EULAR was formerly known as the European League Against Rheumatism. Its current alliance identity emphasizes the participation of multiple stakeholder groups rather than representing only specialist physicians or research institutions. Although it is not a commercial product brand, EULAR operates as a recognizable institutional brand in European rheumatology through its guidelines, journals, congress, educational activities, and policy voice. Publicly available reference material does not establish a conventional corporate ownership structure, stock-market listing, or commercial parent company.

The European Alliance of Associations for Rheumatology is a European non-governmental organization devoted to rheumatology and rheumatic and musculoskeletal diseases. It was formerly known as the European League Against Rheumatism, a name under which the organization developed its European professional, scientific, and advocacy role. The current name presents the organization as an alliance of several constituencies: people affected by rheumatic and musculoskeletal diseases, healthcare professionals, and scientific societies in rheumatology. EULAR's institutional mission is centered on reducing the burden of rheumatic diseases on individuals and society. This includes supporting better prevention, diagnosis, treatment, rehabilitation, and long-term care. The organization also seeks to ensure that advances in rheumatology research are transferred into everyday clinical practice. Its work therefore spans scientific communication, clinical education, professional coordination, patient participation, and engagement with European governing bodies. One of EULAR's most established activities is the publication of evidence-informed recommendations for the diagnosis and treatment of different rheumatic and musculoskeletal diseases. These recommendations are intended to assist clinicians and other healthcare professionals in making consistent, research-informed decisions. Their publication through the Annals of the Rheumatic Diseases and related EULAR channels gives them visibility within the international rheumatology community. Scientific publishing is another central part of EULAR's identity. The organization publishes the Annals of the Rheumatic Diseases and the open-access journal EULAR Rheumatology Open, both through Elsevier. These journals support the communication of research and clinical knowledge across rheumatology and related fields. The open-access publication complements the established specialist journal by making relevant content more broadly available. EULAR's annual scientific meeting, the Annual European Congress of Rheumatology, is a key venue for the organization's educational and professional work. The congress brings together researchers, clinicians, other healthcare professionals, and representatives of patient organizations to discuss research findings, clinical practice, education, and policy. It also reinforces EULAR's role as a network connecting different parts of the European rheumatology community. Over time, EULAR has maintained a role in representing the needs of people with musculoskeletal diseases to policymakers and public institutions in Europe. Its advocacy perspective is linked to the substantial effects of these conditions on health, mobility, quality of life, employment, and social participation. The alliance model allows patient perspectives to be considered alongside scientific and clinical expertise. Publicly supplied reference material does not provide a complete chronology of the organization's founding, leadership succession, headquarters arrangements, or individual program launches. Those details are therefore not asserted here. The available material does establish EULAR's continuing activities in scientific publishing, clinical recommendations, education, congress organization, and European advocacy.

• Established as a European rheumatology organization

  [1]European Alliance of Associations for Rheumatologyen.wikipedia.org

  EULAR developed as a European non-governmental organization representing rheumatology societies, healthcare professionals, and people affected by rheumatic and musculoskeletal diseases. The exact founding year is not specified in the supplied reference material.

• Adoption of the European Alliance of Associations for Rheumatology name

  [1]European Alliance of Associations for Rheumatologyen.wikipedia.org

  The organization formerly operated under the name European League Against Rheumatism and later adopted its current alliance-oriented identity. The supplied reference material does not specify the exact transition year.

• Expansion of scientific publishing

  [1]European Alliance of Associations for Rheumatologyen.wikipedia.org

  EULAR's publication portfolio includes the Annals of the Rheumatic Diseases and the open-access journal EULAR Rheumatology Open, both published by Elsevier.

• Annual European Congress of Rheumatology

  [1]European Alliance of Associations for Rheumatologyen.wikipedia.org

  EULAR established and continues to organize an annual scientific congress serving as a major meeting point for rheumatology research, clinical practice, education, and patient and professional participation.

A pan-European, multi-stakeholder professional and advocacy alliance combining patient representation, rheumatology science, healthcare expertise, education, clinical guidance, and public-policy engagement.

• Medical journal

  Annals of the Rheumatic Diseases

  The Annals of the Rheumatic Diseases is EULAR's established specialist medical journal and a principal channel for rheumatology research, clinical scholarship, and organizational recommendations. It supports the dissemination of evidence relevant to rheumatic and musculoskeletal diseases and is published by Elsevier.

• Open-access medical journal

  EULAR Rheumatology Open

  EULAR Rheumatology Open is EULAR's open-access rheumatology journal. It broadens the organization's publishing activity by providing an openly accessible venue for research and clinical information relating to rheumatology and musculoskeletal disease.

• Clinical guidance

  EULAR recommendations

  EULAR develops recommendations addressing the diagnosis and therapy of various rheumatic and musculoskeletal diseases. These resources are intended to translate research evidence and expert assessment into practical guidance for healthcare professionals and are distributed through EULAR channels and the Annals of the Rheumatic Diseases.

• Scientific congress

  Annual European Congress of Rheumatology

  The Annual European Congress of Rheumatology is EULAR's principal recurring scientific and educational meeting. It provides a platform for research presentations, clinical updates, professional education, networking, and discussion among patient representatives, healthcare professionals, and scientific communities.

1. 1European Alliance of Associations for Rheumatologyen.wikipedia.org
2. 2European Alliance of Associations for Rheumatology official websiteeular.org